AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 277: F850-F858, 1999;
0363-6127/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Purdy, K. E.
Right arrow Articles by Arendshorst, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Purdy, K. E.
Right arrow Articles by Arendshorst, W. J.
Vol. 277, Issue 6, F850-F858, December 1999

Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC

Kit E. Purdy and William J. Arendshorst

Department of Cell and Molecular Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7545

In order to exert an appropriate biological effect, the action of the vasoconstrictive hormone angiotensin II (ANG II) is modulated by vasoactive factors such as prostaglandins PGE2 and PGI2. The present study investigates whether prostaglandins alter ANG II-mediated increases in cytosolic calcium concentration ([Ca2+]i) in vascular smooth muscle cells (VSMC) isolated from rat renal preglomerular arterioles. [Ca2+]i was assessed using the calcium-sensitive dye fura 2 and a microscope-based photometer system. ANG II (10-7 M) caused a biphasic, time-dependent [Ca2+]i response: an initial peak increase from 52 ± 7 to 264 ± 25 nM, followed by a sustained plateau of 95 ± 9 nM in cultured VSMC. Coadministration of PGE2 or PGI2 or synthetic mimetics caused dose-dependent decreases in the peak [Ca2+]i response to ANG II, with attenuation of 40-50%. This degree of inhibition was even more pronounced in individual freshly isolated preglomerular VSMC. Increasing cAMP levels in cultured VSMC, by using either a cell-permeable analog or inhibiting phosphodiesterase activity, mirrored the antagonistic effects of prostaglandins on ANG II-stimulated increases in [Ca2+]i. Radioimmunoassays demonstrate that ANG II (10-7 M) stimulates production of PGI2 and PGE2; the stable prostacyclin metabolite 6-keto-PGF1alpha was released in 10-fold greater concentrations than PGE2. Indomethacin blockade of prostaglandin production potentiated both the peak (264 to 337 ± 26 nM) and sustained [Ca2+]i responses (95 to 181 ± 22 nM) to ANG II. When prostaglandin analogs were added during indomethacin treatment, the ANG II response was restored to the typical pattern. In conclusion, we demonstrate that modulation of intracellular calcium levels is one mechanism by which prostaglandins can buffer ANG II-mediated constriction in renal preglomerular VSMC. PGI2 is more potent than PGE2 in this regard.

renal circulation; afferent arteriole; vascular smooth muscle cells; fura 2; angiotensin II; prostaglandin I2; prostaglandin E2; iloprost; 15-(S)-15-methyl-prostaglandin E2; indomethacin; cyclooxygenase; adenosine 3',5'-cyclic monophosphate; phosphodiesterase


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Joly, R. Seqqat, B. Flamion, N. Caron, A. Michel, J. D. Imig, and R. Kramp
Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R977 - R986.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
F. Helle, O. B. Vagnes, and B. M. Iversen
Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F140 - F147.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. J. Fuller, B. C. Hauschild, R. Gonzalez-Villalobos, M. S. Awayda, J. D. Imig, E. W. Inscho, and L. G. Navar
Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells
Am J Physiol Renal Physiol, October 1, 2005; 289(4): F760 - F767.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. Steendahl, N.-H. Holstein-Rathlou, C. M. Sorensen, and M. Salomonsson
Effects of chloride channel blockers on rat renal vascular responses to angiotensin II and norepinephrine
Am J Physiol Renal Physiol, February 1, 2004; 286(2): F323 - F330.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Alonso-Galicia, K. G. Maier, A. S. Greene, A. W. Cowley Jr., and R. J. Roman
Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R60 - R68.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. D. Imig
Eicosanoid regulation of the renal vasculature
Am J Physiol Renal Physiol, December 1, 2000; 279(6): F965 - F981.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. E. Purdy and W. J. Arendshorst
EP1 and EP4 receptors mediate prostaglandin E2 actions in the microcirculation of rat kidney
Am J Physiol Renal Physiol, October 1, 2000; 279(4): F755 - F764.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online